Forth Worth, TX, United States of America

Brett E Thomes

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Arlington, TX (US) (2013)
  • Fort Worth, TX (US) (2017)
  • Forth Worth, TX (US) (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Brett E Thomes

Introduction

Brett E Thomes is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of ophthalmic devices, holding a total of three patents. His work focuses on enhancing therapeutic agent delivery capabilities in ophthalmic applications.

Latest Patents

One of his latest patents is titled "Ophthalmic device having therapeutic agent delivery capability and method of forming same." This invention is directed towards ophthalmic devices that are loaded with therapeutic agents. The devices are designed to provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agents. Additionally, the therapeutic agent is typically particularly suitable for loading into the ophthalmic material.

Career Highlights

Brett E Thomes has established a successful career in the field of ophthalmic innovations. He is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further develop his inventions and contribute to advancements in eye care.

Collaborations

Brett has collaborated with several talented individuals in his field, including Chi-Chun Tsai and Stephen J Van Noy. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Brett E Thomes is a distinguished inventor whose work in ophthalmic devices has made a significant impact on therapeutic agent delivery. His patents reflect his commitment to improving eye care through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…